|
Market Cap (17-May) $95,239,352 (971st) |
Close (9-Dec) $1.04 |
Volume (9-Dec) 0 |
Shortsold (3-Dec) 50,000 (0.05%) (513th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.144 |
BD1 released this announcement to the ASX on 17 August 2021, 8:39. The announcement is marked as price sensitive, and is 2 page(s) in length and 131.46kb in size.
You can view all announcements from BD1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, BD1 was 0.001% short sold according to ASIC data. It was ranked the 644th most shorted stock on the ASX. It is now ranked as the 513th most shorted stock on the ASX with 0.054% of total shares short sold as of the latest reported data (03 December 2021).
| Other Recent Announcements from BD1 | |
|---|---|
| BARD1 Changes its Name to INOVIQ | 8 December 2021, 8:58 |
| Cleansing Notice - Issued of Four Shares - Resolution 5 AGM | 7 December 2021, 12:12 |
| Application for quotation of securities - BD1 | 7 December 2021, 12:06 |
| Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer Test | 17 August 2021, 8:39 |
| BARD1 LODGES SPP AND OPTIONS PROSPECTUS | 30 July 2021, 10:16 |
| Appendix 4C & Quarterly Activities Report | 30 July 2021, 8:37 |
| Appendix 2A | 29 July 2021, 11:30 |
You must be logged in to post a reply.
BARD1 Life Sciences 